A recently announced agreement between the New Jersey Economic Development Authority and the Israel Innovation Authority is a fitting testament to the theme for the upcoming BIO 2019 International Convention: It Starts with One. In the intensely innovative biotechnology space, one meeting; one interaction; one study, one partnership, one discovery, or one presentation can change the trajectory of progress.
On October 11, 2018, the New Jersey Economic Development Authority and the Israel Innovation Authority (IIA) signed a Memorandum of Understanding that was initiated from conversations held at the 2018 BIO International Convention in Boston.
The relationship began when Choose New Jersey CEO Jose Lozano attended a presentation given at the June Convention by long-term conference attendee, IIA, ROI reports. Impressed by the presentation, Lozano and his team connected with IIA staff before the end of the conference and the rest was history.
The October memorandum was signed days before New Jersey Governor Phil Murphy set out on a nine-day global economy mission with an important stop in Israel. The partnership encourages collaboration between New Jersey corporations and Israeli businesses- specifically it aims to strengthen research and development of the innovation economy, including the biotechnology and the life sciences industries.
In a press release on the memorandum, Governor Murphy noted,
“The Garden State and Israel both have economies deeply rooted in innovation as well as brilliant scientists, researchers, and academic minds doing ground-breaking work across a broad spectrum of high-growth sectors. The New Jersey-Israel relationship already generates more than $1 billion in annual shared economic activity and we hope that, as a result of this MOU, that number will double, if not triple, in the years ahead.”
To read more about the partnership between New Jersey & Israel, visit:
- New Jersey & Israel Sign Agreement to Strengthen Economic Ties
- Innovation is the Theme of Governor Murphy’s First Full Day in Israel
This is only one of the many cross-border collaborations that have stemmed from the educational, networking, and partnering opportunities at the BIO International Convention.
As the world’s largest biotechnology event, the BIO International Convention attracts 16,000+ global biotechnology and pharma influencers for one week of intense networking to discover new opportunities and promising partnerships. Event attendees can connect with global counterparts in the industry to foster new breakthroughs in innovation that help us heal, fuel, and feed the world.